Flutinase Polynex, Nasentropfen, Suspension in Einzeldosen

7680548850164 CH-54885 Nasentropfen
Flutinase Polynex, Nasentropfen, Suspension in Einzeldosen
Flutinase Polynex, Nasentropfen, Suspension in Einzeldosen
Flutinase Polynex, Nasentropfen, Suspension in Einzeldosen
1 / 3
google

Article details

Package size
28
Selling units
28
Measure
Einzeldose(n)
Galenic form
Nasentropfen
Galenic group
Nasenmittel

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/06/2025
Patient information leaflet
Français
27/06/2025
Patient information leaflet
Italien
27/06/2025
Summary of Product Characteristics
Allemand
27/06/2025
Summary of Product Characteristics
Français
27/06/2025
Summary of Product Characteristics
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
400.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
54885
Drug name
Flutinase Polynex, Nasentropfen, Suspension in Einzeldosen
Galenic form
NASNS
ATC Code
R01AD08
Authorization status
Z
Dispensing category
B
First authorization
25/06/1999
Authorization expiration date
31/12/9999
IT Number
12.02.3.
Domain
Human medicine
Field of application
Kortikoid-Rhinologikum zur Behandlung von Nasenpolypen

Package details

Description (FR)
FLUTINASE Polynex susp 28 monodos 0.4 ml
Description (DE)
FLUTINASE Polynex Susp 28 Monodos 0.4 ml
Market launch
25/06/1999
Narcotic (BTM)
No

Available generics (1)

Nasofan, Nasenspray, Suspension
GTIN: 7680581690048
CHF 31.25
View